Model
Edge
Neos Therapeutics, Inc.
0001467652
Filing Type
425
Filing Date
3/21/2021
Updated
3/22/21, 12:09 AM
Filing
425
Earnings Release
Exhibits
425
CURRENT REPORT
EX-3.1
FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEOS THERAPEUTICS, INC
EX-3.2
SECOND AMENDED AND RESTATED BYLAWS OF NEOS THERAPEUTICS, INC
EX-10.1
CONSENT, WAIVER AND SIXTH AMENDMENT TO FACILITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, LLC, DEERFIELD PRIVATE DESIGN
EX-10.2
CONSENT, WAIVER AND AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, AND ENCINA BUSINESS
EX-99.1
PRESS RELEASE DATED MARCH 22, 2021